Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD

References

• GagnonPGuenetteJALangerDPathogenesis of hyperinflation in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2014918720124600216
   PubMed Web of Science ®Google Scholar
• ZanenPRuttenFHoesALammersJPrevalence of hyperinflation in COPD and correlation with flow-volume indicesChest20051284 Suppl132S133S
   Web of Science ®Google Scholar
• O’DonnellDELavenezianaPPhysiology and consequences of lung hyperinflation in COPDEur Respir Rev2006151006167
   Google Scholar
• OhYMSheenSSParkJHEmphysematous phenotype is an independent predictor for frequent exacerbation of COPDInt J Tuberc Lung Dis201418121407141425517804
   PubMed Web of Science ®Google Scholar
• ShinTROhYMParkJHThe prognostic value of residual volume/total lung capacity in patients with chronic obstructive pulmonary diseaseJ Korean Med Sci201530101459146526425043
   PubMed Web of Science ®Google Scholar
• BudweiserSHarlacherMPfeiferMJorresRACo-morbidities and hyperinflation are independent risk factors of all-cause mortality in very severe COPDCOPD201411438840024111878
   PubMedGoogle Scholar
• DiazOVillafrancaCGhezzoHRole of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at restEur Respir J200016226927510968502
   PubMed Web of Science ®Google Scholar
• O’DonnellDERevillSMWebbKADynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2001164577077711549531
   PubMed Web of Science ®Google Scholar
• CasanovaCCoteCde TorresJPInspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005171659159715591470
   PubMed Web of Science ®Google Scholar
• CortopassiFCelliBDivoMPinto-PlataVLongitudinal changes in handgrip strength, hyperinflation, and 6-minute walk distance in patients with COPD and a control groupChest2015148498699425996450
   PubMed Web of Science ®Google Scholar
• LeeJSKimSOSeoJBLongitudinal lung volume changes in patients with chronic obstructive pulmonary diseaseLung2013191440541223715996
   PubMed Web of Science ®Google Scholar
• OzgürESNayciSAOzgeCTaşdelenBAn integrated index combined by dynamic hyperinflation and exercise capacity in the prediction of morbidity and mortality in COPDRespir Care20125791452145922348294
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• CelliBRPredictors of mortality in COPDRespir Med2010104677377920417082
   PubMed Web of Science ®Google Scholar
• CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med2004350101005101214999112
   PubMed Web of Science ®Google Scholar
• WilliamsJEGreenRHWarringtonVSteinerMCMorganMDSinghSJDevelopment of the i-BODE: validation of the incremental shuttle walking test within the BODE indexRespir Med2012106339039621978938
   PubMed Web of Science ®Google Scholar
• WibmerTRüdigerSKropf-SanchenCStoiberKMRottbauerWSchumannCRelation of exercise capacity with lung volumes before and after 6-minute walk test in subjects with COPDRespir Care201459111687169525249649
   PubMed Web of Science ®Google Scholar
• O’DonnellDEFlügeTGerkenFEffects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEur Respir J200423683284015218994
   PubMed Web of Science ®Google Scholar
• Puente-MaestuLStringerWWHyperinflation and its management in COPDInt J Chron Obstruct Pulmon Dis20061438140018044095
   PubMedGoogle Scholar
• TashkinDPCooperCBThe role of long-acting bronchodilators in the management of stable COPDChest2004125124925914718448
   PubMed Web of Science ®Google Scholar
• CazzolaMPPageCLong-acting bronchodilators in COPD: where are we now and where are we going?Breathe2014102111120
   Google Scholar
• HananiaNADonohueJFPharmacologic interventions in chronic obstructive pulmonary disease: bronchodilatorsProc Am Thorac Soc20074752653417878465
   PubMedGoogle Scholar
• Electronic Medicines CompendiumIncruse 55 micrograms inhalation powder, pre-dispensed [summary of product characteristics]2017 Available from: http://www.medicines.org.uk/emc/medicine/29394Accessed September 28, 2017
   Google Scholar
• Electronic Medicines CompendiumAnoro Ellipta 55 micrograms/22 micrograms inhalation powder, pre-dispensed [summary of product characteristics] Available from: http://www.medicines.org.uk/emc/medicine/28949Accessed September 28, 2017
   Google Scholar
• MaltaisFSinghSDonaldACEffects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trialsTher Adv Respir Dis20148616918125452426
   PubMed Web of Science ®Google Scholar
• SinghSMaltaisFTombsLFahyWAVahdati-BolouriMRileyJHA comparison of shuttle walking test endpoints in exercise studies in patients with COPDThorax201570Suppl 3A149
   Google Scholar
• SinghSMaltaisFTombsLChurchAIqbalARileyJHEffect of umeclidinium/vilanterol (Umec/Vi) on inspiratory capacity/total lung capacity ratio in hyperinflated COPD patientsEur Respir J201546Suppl 59A1493
   Google Scholar
• HartmanJETen HackenNHKloosterKBoezenHMde GreefMHSlebosDJThe minimal important difference for residual volume in patients with severe emphysemaEur Respir J20124051137114122441742
   PubMed Web of Science ®Google Scholar
• StocksJQuanjerPHReference values for residual volume, functional residual capacity and total lung capacityEur Respir J1995834925067789503
   PubMed Web of Science ®Google Scholar
• WangerJClausenJLCoatesAStandardisation of the measurement of lung volumesEur Respir J200526351152216135736
   PubMed Web of Science ®Google Scholar
• RevillSMMorganMDSinghSJWilliamsJHardmanAEThe endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary diseaseThorax199954321322210325896
   PubMed Web of Science ®Google Scholar
• SinghSJMorganMDHardmanAERoweCBardsleyPAComparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitationEur Respir J1994711201620207875275
   PubMed Web of Science ®Google Scholar
• PepinVLavioletteLBrouillardCSignificance of changes in endurance shuttle walking performanceThorax201166211512021148135
   PubMed Web of Science ®Google Scholar
• Garcia-RioFLoresVMedianoODaily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflationAm J Respir Crit Care Med2009180650651219542481
   PubMed Web of Science ®Google Scholar
• O’DonnellDEWebbKAThe major limitation to exercise performance in COPD is dynamic hyperinflationJ Appl Physiol (1985)2008105275375518678624
   PubMed Web of Science ®Google Scholar
• AlbuquerqueALNeryLEVillacaDSInspiratory fraction and exercise impairment in COPD patients GOLD stages II–IIIEur Respir J200628593994416870665
   PubMed Web of Science ®Google Scholar
• ZhangYSunXGYangWLTanXYLiuJMInspiratory fraction correlates with exercise capacity in patients with stable moderate to severe COPDRespir Care201358111923193023592787
   PubMed Web of Science ®Google Scholar
• O’DonnellDELamMWebbKASpirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1999160254254910430726
   PubMed Web of Science ®Google Scholar